Elsevier and Medical Education Technologies, Inc. Collaborate to Offer Simulation Technology for Health Science Curriculums

By Elsevier, PRNE
Sunday, May 22, 2011

ST. LOUIS, Missouri, May 23, 2011 -

- Partnership Fully Integrates Nursing Education Content and Solutions
With Human Patient Simulators

Elsevier, (www.elsevier.com/wps/find/homepage.cws_home)
the leading global publisher of scientific, technical, and medical
information products and services, announced today a partnership agreement
with Medical Education Technologies, Inc. (www.meti.com/index.html )
(METI), a leading manufacturer of medical simulation and health care learning
technologies. The companies will collaborate to release a turn-key health
care education product that combines Elsevier's nursing education content
with METI's human patient simulators.

"Nursing programs around the country are looking for more
effective ways to prepare the future health care workforce for success in the
realities of clinical practice," said Tom Wilhelm, Vice President,
e-solutions, Elsevier Nursing and Health Professions. "This new solution will
provide nursing students with hands-on learning when clinical space is at a
premium, and offer the training and experience they need to handle new and
emerging best practices and technologies. For educators, this product
provides a solution that enables them to deliver simulated clinical
experiences without having to manually change each setting in the patient

Elsevier and METI will combine METI's human patient simulators
integrated with Müse(R), a medical trainer's simulator operating software,
with Elsevier's current suite of nursing simulation products, including Sim
, a new simulated EHR and charting system, and Simulation Learning
System (SLS), an online toolkit that helps instructors and facilitators
effectively standardize and incorporate medium to high fidelity simulation
into their nursing curriculum.

"Elsevier and METI's new offering is a seamless solution that
will make it much easier for us to integrate simulation activities into our
nursing program and provide more comprehensive training for future nurses,"
said Kim Leighton, Dean of Educational Technology, BryanLGH College of Health
Sciences. "The new product will allow us to spend more time preparing our
students for real-life clinical situations they will face in the workplace,
and less time preparing our simulation activities."

The combined solution is available to nursing education
programs and schools through Elsevier or METI. Customers who have already
purchased a METI human patient simulator can integrate the Elsevier content
for the complete solution. Elsevier will also continue to offer its education
content without METI simulators, and METI simulators are available without
Elsevier content. More information can be found at
www.elsevieradvantage.com/simulations/ or

"This partnership comes at a crucial time because of the
current shortage of clinical sites for nursing and health professional
education," said Michael Bernstein, President and CEO of METI. "In addition,
incentives in the government's recent health care legislation are driving
increased adoption of simulation technology. Elsevier is highly regarded in
nursing education and shares our vision and commitment to provide technology
that supports the direction health care is going and the advancement of
real-world training that improves patient safety and ultimately, saves

About METI

Based in Sarasota, Florida, METI has been a leader in
interactive human patient simulation since 1996. The entire family of METI
simulators, including baby, pediatric and adults, are designed to mimic human
medical scenarios including trauma, heart attack, drug overdose and effects
of bioterrorism. Today, more than 7,000 METI simulators are in use worldwide
by defense organizations, medical schools, nursing schools, hospitals and
other entities involved in healthcare education. METI is privately owned by
Lou Oberndorf and Baird Capital Partners (BCP) of Chicago.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet (www.meti.com/index.html) and Cell,
(www.cell.com/) and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect, (www.sciencedirect.com/) SciVerse Scopus,
(www.scopus.com/home.url) Reaxys, (https://www.reaxys.com/info/) MD
Consult (www.mdconsult.com/php/249791713-138/homepage) and Nursing
Consult, (
which enhance the productivity of science and health professionals, and the
SciVal suite (www.scival.com/) and MEDai's Pinpoint Review,
(www.medai.com/) which help research and health care institutions
deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC, (
www.reedelsevier.com/Pages/Home.aspx) a world-leading publisher and
information provider, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact

    Tom Reller
    Vice President, Global Corporate Relations


will not be displayed